Bobby Singh

Bobby Singh is an accomplished pharmaceutical executive with extensive leadership experience in drug development and commercialization. Currently serving as Chief Executive Officer at Corsair Pharma since August 2020, Bobby previously held the position of Chief Technology Officer at Corium, Inc. from January 2002 to August 2020, where significant contributions included overseeing R&D, leading the development of innovative drug delivery platforms, and managing major corporate partnerships. Prior to Corium, Bobby was the Director at Vyteris in 2001, commercializing a drug-device combination product, and held roles at Novartis from 1995 to 2000, where Bobby established a technology initiative for iontophoresis drug delivery and advanced formulation development.